Valuation Merck KGaA

Equities

Market Closed - Xetra Other stock markets 16:36:55 19/05/2026 BST			5-day change	1st Jan Change
120.35 ^EUR	+2.21%		+6.60%	-1.84%

10:00am	Merck KGaA: From 19th-century cocaine to tomorrow's AI chips
05:51am	Bernstein Expects Merck KGaA ROIC to Outpace WACC Earlier; Price Target, Estimates Up	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	98,695	78,651	62,651	60,825	53,304	52,326	-	-
Change	-	-20.31%	-20.34%	-2.91%	-12.37%	-1.84%	-	-
Enterprise Value (EV) ¹	107,596	86,979	70,610	68,609	62,533	59,946	57,859	55,822
Change	-	-19.16%	-18.82%	-2.83%	-8.86%	-4.14%	-3.48%	-3.52%
P/E ratio	32.3x	23.6x	22.2x	21.9x	20.4x	20.2x	17.5x	15.6x
PBR	4.63x	3.03x	2.35x	2.03x	1.86x	1.73x	1.62x	1.51x
PEG	-	2.68x	-1.5x	-14.21x	-3.34x	-42.9x	1.2x	1.3x
Capitalization / Revenue	5.01x	3.54x	2.98x	2.88x	2.53x	2.49x	2.38x	2.25x
EV / Revenue	5.47x	3.91x	3.36x	3.24x	2.96x	2.86x	2.63x	2.4x
EV / EBITDA	17.6x	12.7x	12x	11.3x	10.2x	10.1x	9.15x	8.22x
EV / EBIT	25.7x	19.4x	19.6x	18.8x	17.4x	16.4x	14.3x	12.5x
EV / FCF	30.3x	31.9x	36.9x	23.8x	26.6x	20.2x	18.5x	16.5x
FCF Yield	3.3%	3.14%	2.71%	4.2%	3.75%	4.96%	5.39%	6.06%
Dividend per Share ²	1.85	2.2	2.2	2.2	2.2	2.338	2.432	2.537
Rate of return	0.81%	1.22%	1.53%	1.57%	1.79%	1.94%	2.02%	2.11%
EPS ²	7.03	7.65	6.49	6.39	6	5.972	6.866	7.709
Distribution rate	26.3%	28.8%	33.9%	34.4%	36.7%	39.1%	35.4%	32.9%
Net sales ¹	19,687	22,232	20,993	21,156	21,102	20,987	22,007	23,227
EBITDA ¹	6,103	6,849	5,879	6,072	6,109	5,909	6,322	6,791
EBIT ¹	4,179	4,474	3,609	3,645	3,601	3,660	4,036	4,484
Net income ¹	3,055	3,326	2,824	2,777	2,608	2,592	2,956	3,302
Net Debt ¹	8,902	8,328	7,959	7,784	9,229	7,620	5,534	3,496
Reference price ²	227.00	180.90	144.10	139.90	122.60	120.35	120.35	120.35
Nbr of stocks (in thousands)	434,778	434,778	434,778	434,778	434,778	434,778	-	-
Announcement Date	03/03/22	02/03/23	07/03/24	06/03/25	05/03/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK KGAA	19.69x	2.8x	10x	1.99%	59.58B
HALOZYME THERAPEUTICS, INC.	10.02x	5.12x	8.06x	-	8B
KYOWA KIRIN CO., LTD.	15.05x	1.86x	6.6x	2.94%	7.6B
SK BIOPHARMACEUTICALS CO., LTD.	25.09x	7.24x	19.9x	-.--%	5B
YUHAN CORPORATION	44.91x	2.62x	31.92x	0.66%	4.14B
BETTA PHARMACEUTICALS CO., LTD.	26.2x	5.04x	14.42x	-	3.03B
SUPERNUS PHARMACEUTICALS, INC.	111.53x	-	-	-.--%	2.81B
Average	36.07x	4.11x	15.15x	1.12%	12.88B
Weighted average by Cap.	22.98x	3.25x	11.29x	1.81%